Pharmaceutical
Technology
Health

Titan Pharmaceuticals

59,255

$0.305
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0112 (-3.66%) Today
+$0.01 (+3.39%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell TTNP and other stocks, options, ETFs, and crypto commission-free!

About TTNP

Titan Pharmaceuticals, Inc. engages in development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, ProNeura. Its lead product is Probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. Read More The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.

CEO
Sunil Bhonsle
Employees
21
Headquarters
South San Francisco, California
Founded
1992
Market Cap
28.22M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
18.78M
High Today
$0.305
Low Today
$0.29
Open Price
$0.292
Volume
6.20M
52 Week High
$1.40
52 Week Low
$0.142

Collections

Pharmaceutical
Technology
Health
Biopharmaceutical
Therapy
Medical
US
North America

TTNP News

ReutersJun 30

BRIEF-Titan Pharmaceuticals - Cash Resources Are Only Sufficient To Fund Operations Through Q3 Of This Year

June 30 (Reuters) - Titan Pharmaceuticals Inc: * TITAN PHARMACEUTICALS - CO’S CURRENT CASH RESOURCES ARE ONLY SUFFICIENT TO FUND OPERATIONS THROUGH Q3 OF THIS
0

TTNP Earnings

-$0.62
-$0.41
-$0.21
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 12, After Hours

You May Also Like

CLSK
AR
WMT
CTAS
OLED
GHM
RF-A
NYMX
AJX
TEN
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy TTNP

Market Price$0.305
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell TTNP stock and options commission-free.
LearnBlogCareersHelpLog InSign Up